Apidra SoloStar
Active substance: insulin glulisine
INJECTION, SOLUTION · INSULIN GLULISINE 100 [iU]/mL
United StatesActive
Marketing holder: sanofi-aventis U.S. LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- INSULIN GLULISINE · 100 [iU]/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12093-43de-75ba-96c0-94a07d773e91,01a12095-758b-74fa-837e-fea58c09cf9c;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0088-2502
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0088-2502 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0088-2502 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0088-2502 · Verified 2026-10-09 · open in source